Evidence map›Paper›PMID 38685762›Full record

ArticleGut microbes

Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.

Murad Ishnaiwer, Quentin Le Bastard, Maxime Naour, Michal Zeman, Eric Dailly, Emmanuel Montassier, Eric Batard, Michel Dion

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Study ofInternational journal of inflammation · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Murad IshnaiwerNantes Université, CHU Nantes, Cibles et médicaments des infections et du cancer, IICiMed, Nantes, France.
Quentin Le BastardNantes Université, CHU Nantes, Cibles et médicaments des infections et du cancer, IICiMed, Nantes, France.
Maxime NaourNantes Université, INRAE, Nantes, France.
Michal ZemanVeterinary Research Institute, Brno, Czech Republic.
Eric DaillyNantes Université, CHU Nantes, Cibles et médicaments des infections et du cancer, IICiMed, Nantes, France.
Emmanuel MontassierNantes Université, CHU Nantes, Cibles et médicaments des infections et du cancer, IICiMed, Nantes, France.
Eric BatardNantes Université, CHU Nantes, Cibles et médicaments des infections et du cancer, IICiMed, Nantes, France.
Michel DionNantes Université, CHU Nantes, Cibles et médicaments des infections et du cancer, IICiMed, Nantes, France.ORCID 0000-0002-5443-1362
Centre Hospitalier Universitaire de Nantes · FRCibles et Médicaments des Infections et de l'ImmunitéInserm · FRInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRPalestine Polytechnic University · PSVeterinary Research Institute · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inulin, an increasingly studied dietary fiber, alters intestinal microbiota. The aim of this study was to assess whether inulin decreases intestinal colonization by multidrug resistant

Indexed as

AmoxicillinDrug Resistance, Multiple, BacterialEscherichia coliFecesGastrointestinal MicrobiomeInulinPantoprazoleAnimalsAnti-Bacterial Agentsbeta-LactamasesDysbiosisEscherichia coli InfectionsFemaleMicePrebioticsAmoxicillinAnti-Bacterial Agentsbeta-LactamasesInulinPantoprazolePrebioticsEscherichia coliintestinal colonizationInulinmicrobiomemulti-drug resistanceprebioticsresistome

Identifiers

PMID38685762
PMCPMC11062366
OpenAlexW4396517778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.